Inicio › Dermatitis atópica (eccema) › Florida

Ensayos clínicos de Dermatitis atópica (eccema) en Florida

18 estudios sobre Dermatitis atópica (eccema) buscan participantes en Florida.

Ciudades en Florida

Texto oficial del estudio (inglés)

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Clinical Site 110, Miami

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 18 a 65 · Todos los sexos · Actualizado el 29 sept 2026 · NCT07453602

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

St. Jude Clinical Research- Site Number : 8400049, Doral
Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach

ReclutandoEstudio observacional

Edades de 12 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

Novartis Investigative Site, Miami
Novartis Investigative Site, St. Petersburg

ReclutandoFase 2

Edades de 18 a 100 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06947993

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

Gsi Clinical Research, Margate

ReclutandoFase 2

Edades de 18 a 64 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07216027

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Solutions Through Advanced Research, Jacksonville

ReclutandoFase 3

Edades de 2 a 11 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06807281

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Fort Lauderdale
Enveda Investigative Site, Miami
Enveda Investigative Site, Miramar

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07298395

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Investigational Site, Coral Gables
Investigational Site, Jacksonville
Investigational Site, Margate

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07003425

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

AllerVie Clinical Research, Panama City
GCP Research , Global Clinical Professionals, St. Petersburg

ReclutandoFase 3

Edades de 12 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07765888

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

Olympian Clinical Research, Tampa

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07223697

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

ABMED Clinical Research Corp., Cape Coral
Skin Care Research, Hollywood
Quality Care Clinical Research, Miami
y 4 más

ReclutandoFase 2

Edades de 18 a 65 · Todos los sexos · Actualizado el 28 ago 2026 · NCT07599813

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

Inmagene Site 19, Ocala
Inmagene Site 4, Tampa

ReclutandoFase 2

Edades de 18 a 74 · Todos los sexos · Actualizado el 12 ago 2026 · NCT07037901

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Pediatric Skin Research - Coral Gables /ID# 266308, Coral Gables

ReclutandoFase 3

Edades de 2 a 11 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06461897

A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Enveda Investigative Site, Boca Raton

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT07643766

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Miami Dermatology and Laser Research, Miami

ReclutandoFase 1Se aceptan voluntarios sanos

Edades de 18 a 70 · Todos los sexos · Actualizado el 22 jul 2026 · NCT06564389

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Leo Pharma Investigational site, Jacksonville
Leo Pharma Investigational site, Miami
Leo Pharma Investigational site, Tampa

ReclutandoFase 3

6 Months – 11 Years · Todos los sexos · Actualizado el 7 jul 2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Skin Care Research Boca Raton /ID# 263733, Boca Raton
TrueBlue Clinical Research - Brandon /ID# 265037, Brandon
Life Clinical Trials - Coral Springs /ID# 267195, Coral Springs
y 13 más

ReclutandoFase 3

Edades de 18 a 63 · Todos los sexos · Actualizado el 6 jul 2026 · NCT06389136

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Revival Research, Doral
Floridian Research Institute Llc, Miami
Global Health Research Center, Inc., Miami Lakes
y 4 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 may 2026 · NCT05995964

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Galderma Investigational Site 8597, Boca Raton
Galderma Investigational Site 7087, Coral Gables
Galderma Investigational Site 7063, Cutler Bay
y 7 más

ReclutandoEstudio observacional

Edades de 12 en adelante · Todos los sexos · Actualizado el 13 mar 2026 · NCT06988605

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.